Cardiologists Face Setback with New Heart Drug
Until recently, cardiologists believed they were nearing a breakthrough in heart disease treatment. Three companies were running extensive clinical trials to test drugs that reduce the levels of a blood protein known as Lp(a), associated with heart attacks and strokes. Doctors were optimistic, hoping this new drug would be as significant as statins. However, when […]






